Psoriatic Arthritis

Percentage of Psoriatic Arthritis Patients Taking Small Molecules and Biologics as Medication Therapy (2016-2020)

Percentage of Psoriatic Arthritis Patients Taking Small Molecules and Biologics as Medication Therapy (N=1819)

2016-2020

American College of Rheumatology guidelines recommend that psoriatic arthritis patients be treated with small molecules and biologics as medication therapy. More than 94% of psoriatic arthritis patients who were seen in the Department of Rheumatology at least 2 times during the years 2016–2020 were treated with small molecules and biologics as medication therapy. Reasons for not prescribing these therapies for the small percentage of patients not taking them included disease remission, refusal of treatment, and contraindications to this type of therapy. In any given year, between 93% and 96% of patients were on a small molecule or biologic medication.